Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease

Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease

US Patent 8476408 · Granted Jul 2, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Composition of extracellular vesicles (EVS) and medical uses thereof2025
Composition of extracellular vesicles (EVS) and medical uses thereof2022
Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic d2021
Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic d2020
Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders2012
Methods for promoting growth and survival of insulin-secreting cells2011
Use of ghrelin and unacylated ghrelin compositions for treating insulin resistan2010
Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses2009
Treatment of tumors by administration of growth hormone releasing compounds and 2000
Pharmaceutical composition for intranasal administration, comprising GH-releasin1991